- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04624087
Go/No-Go Intervention for Weight Loss
March 17, 2022 updated by: University of Minnesota
The Effect of Go/No-Go Training Dosage on Weight Loss, Food Evaluation, and Disinhibition in Overweight and Obese Individuals: A Randomized Controlled Trial
The purpose of this study is to assess the effect of a food-specific Go/No-Go (GNG) computerized training task on weight loss, food evaluation, and disinhibition in a population of overweight and obese individuals.
Study Overview
Status
Completed
Conditions
Detailed Description
Within the current obesogenic environment, the prevalence of overweight and obesity has dramatically increased over the past 40 years.
As a result, approximately 40% of Americans attest to being on a diet, with most of these efforts being unsuccessful.
Most weight loss diets rely on self-control and reflective thinking (e.g., making conscious food choices multiple times per day), despite the fact that responses to appetitive foods often occur through implicit (unconscious) processes.
The proposed study is a randomized clinical trial for weight loss that targets these implicit processes through the use of a computerized, food-specific, go/no-go task.
This task has previously resulted in reduced food consumption in laboratory settings, and small but significant weight loss in two brief intervention studies.
The purpose of this study is to replicate one prior study and to compare different doses of the intervention.
Participants will be assigned to one of three groups: high intensity, low intensity, or active control, and will be assessed on a number of variables pre- and post-intervention.
Changes in body weight, food evaluation, frequency of self-reported food consumption, and eating disinhibition scores will be evaluated.
It is hypothesized that individuals receiving the food-specific go/no-go training (high intensity and low intensity groups) will experience greater weight loss, decreased disinhibition with food, and reduced snacking of the targeted foods than those in the active control group.
It is also hypothesized that the high intensity intervention will be more effective than the low intensity intervention across these variables.
Moderators (e.g., dietary restraint, disinhibition) will also be explored throughout this study, along with the mechanism of devaluation of specific foods.
Study Type
Interventional
Enrollment (Actual)
78
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Minnesota
-
Duluth, Minnesota, United States, 55812
- University of Minnesota Duluth
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Body Mass Index (BMI) ≥ 25
- Age ≥ 18
- Consume some of the determined "no-go" snack foods at least three times per week (assessed using a food frequency questionnaire)
- A desire to lose weight
Exclusion Criteria:
- Medical condition limiting dietary intake
- Medical condition directly affecting weight
- Current use of weight loss medication
- Actively enrolled in a formal weight loss program currently or within the past 6 months (e.g., Weight Watchers)
- History of bariatric surgery
- Currently pregnant
- Current smoker
- Smoking cessation within the past year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: High Dose
Participants will perform the food-specific computerized go/no-go training four times per week for 4 weeks.
|
Participants will perform the computerized food specific go/no-go training a designated number of times over a four week duration (frequency varies by group).
Each training session will last approximately 10 minutes and occur on different days of the week.
|
|
EXPERIMENTAL: Low Dose
Participants will perform the food-specific computerized go/no-go training one time per week for 4 weeks.
|
Participants will perform the computerized food specific go/no-go training a designated number of times over a four week duration (frequency varies by group).
Each training session will last approximately 10 minutes and occur on different days of the week.
|
|
ACTIVE_COMPARATOR: Active Control
Participants will perform the generalized, nonfood-specific computerized go/no-go training one time per week for 4 weeks.
|
Participants will perform the computerized general go/no-go training 1 time per week over a four week duration.
Each training session will last approximately 10 minutes and occur on different days of the week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in body weight from baseline to post 4-week intervention, to 6-month follow-up
Time Frame: baseline, post 4-week intervention, 6-month follow-up
|
Body weight will be measured by participant using personal or university scale.
Participants will take a picture of their weight send it to the research team (Due to COVID-19 precautions, in person weighing is not possible).
|
baseline, post 4-week intervention, 6-month follow-up
|
|
Change in disinhibition scores from baseline to post 4-week intervention, to 6-month follow-up.
Time Frame: baseline, post 4-week intervention, 6-month follow-up
|
This will be measured using the Disinhibition subscale of the Three Factor Eating Questionnaire; minimum value = 0; maximum value = 16; higher scores for this measure means worse outcomes
|
baseline, post 4-week intervention, 6-month follow-up
|
|
Change in frequency of food consumption from baseline to post 4-week intervention, to 6-month follow-up.
Time Frame: baseline, post 4-week intervention, 6-month follow-up
|
This will be measured using a food frequency questionnaire assessing food intake over the previous month.
|
baseline, post 4-week intervention, 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in binge eating behaviors from baseline to post 4-week intervention, to 6-month follow-up.
Time Frame: baseline, post 4-week intervention, 6-month follow-up
|
This will be measured using the binge eating questions of the Eating Disorder Examination Questionnaire; minimum value = 0; maximum value = unlimited; higher scores for this measure means worse outcomes
|
baseline, post 4-week intervention, 6-month follow-up
|
|
Change in liking of foods from baseline to post 4-week intervention, to 6-month
Time Frame: baseline, post 4-week intervention, 6-month follow-up
|
This will be measured using a visual analog scale; minimum value = -100; maximum value = 100; higher scores for this measure on healthy foods means better outcomes, higher scores on this measure for unhealthy foods means worse outcomes
|
baseline, post 4-week intervention, 6-month follow-up
|
|
Change in automatic responses to healthy and unhealthy foods from baseline to post 4-week intervention, to 6-month
Time Frame: baseline, post 4-week intervention, 6-month follow-up
|
This will be measured using an impulsive food choice test.
|
baseline, post 4-week intervention, 6-month follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
October 19, 2020
Primary Completion (ACTUAL)
November 1, 2021
Study Completion (ACTUAL)
November 1, 2021
Study Registration Dates
First Submitted
October 13, 2020
First Submitted That Met QC Criteria
November 9, 2020
First Posted (ACTUAL)
November 10, 2020
Study Record Updates
Last Update Posted (ACTUAL)
March 21, 2022
Last Update Submitted That Met QC Criteria
March 17, 2022
Last Verified
March 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 00010522
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Overweight and Obesity
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Institut Investigacio Sanitaria Pere VirgiliCompletedObesity, Childhood | Overweight and Obesity | Overweight, ChildhoodSpain
-
National University Health System, SingaporeActive, not recruitingObesity | Overweight and/or Obesity | Overweight or Obese Adults | Overweight , ObesitySingapore
-
National Taiwan University HospitalCompleted
-
Holbaek SygehusUniversity of Copenhagen; University of Florida; University of Minnesota; Hebrew... and other collaboratorsRecruitingChildhood Overweight and ObesityDenmark
-
PfizerRecruitingObesity | Overnutrition | Nutrition Disorders | Overweight | Body Weight | Overweight or Obesity | Overweight and/or Obesity | Nutritional and Metabolic DiseasesUnited States
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasRecruitingPediatric Obesity | Pediatric Overweight | Overweight , ObesityUnited States
-
Universidade do Extremo Sul Catarinense - Unidade...RecruitingObesity | Overweight and Obesity | Obesity; Endocrine | Overweight, Obesity and Other HyperalimentationBrazil
-
Mexican National Institute of Public HealthUNICEFCompleted
-
Universidade do PortoFundação para a Ciência e a Tecnologia; Administração Regional de Saúde do... and other collaboratorsCompletedOverweight and ObesityPortugal
Clinical Trials on food-specific go/no-go computerized training
-
North Dakota State UniversityUnknown
-
Istituti Clinici Scientifici Maugeri SpAASST Fatebenefratelli Sacco; Istituto Psicologico Italiano s.r.l.s.RecruitingAnorexia Nervosa | Bulimia Nervosa | ARFID | Executive Functions | Cognitive Flexibility | Implicit Association TestItaly
-
Northwestern UniversityCompleted
-
Johns Hopkins UniversityCompleted
-
Loma Linda UniversityOregon Research InstituteTerminated
-
University of California, Los AngelesUnknown
-
University of OttawaMitacs; Banting Research Foundation; Perley HealthRecruitingAging | Cognition | Physical Inactivity | Bias, Implicit | Sedentary BehaviorsCanada
-
University of North Carolina, Chapel HillNorth Carolina Translational and Clinical Sciences InstituteCompletedStress | Emotional Disturbances | Adolescent DevelopmentUnited States
-
Hospices Civils de LyonCompletedAnorexia Nervosa | Bulimia Nervosa | Binge EatingFrance
-
Hugo W. Moser Research Institute at Kennedy Krieger...National Institute of Mental Health (NIMH)RecruitingPhysical Activity | Sleep | Attention Deficit Hyperactivity Disorder (ADHD)United States